Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)
Technology appraisal
Reference number: TA570
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.